Akoya Biosciences Inc (NASDAQ: AKYA) Shares Inclined By 11.97% In One Month.

In the latest trading session,, 12.91 million Akoya Biosciences Inc (NASDAQ:AKYA) shares changed hands as the company’s beta touched 1.26. With the company’s most recent per share price at $1.31 changing hands around $0.25 or 23.58% at last look, the market valuation stands at $65.34M. AKYA’s current price is a discount, trading about -161.07% off its 52-week high of $3.42. The share price had its 52-week low at $0.93, which suggests the last value was 29.01% up since then.

Analysts gave the Akoya Biosciences Inc (AKYA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended AKYA as a Hold, 5 felt it is a Buy and 0 rated the stock as Underweight.

Akoya Biosciences Inc (NASDAQ:AKYA) trade information

Instantly AKYA is in green as seen in intraday trades today. With action 38.52%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -42.79%, with the 5-day performance at 38.52% in the green. However, in the 30-day time frame, Akoya Biosciences Inc (NASDAQ:AKYA) is 11.97% up.

The consensus price target for the stock as assigned by Wall Street analysts is 2.4, meaning bulls need an upside of 45.42% from its recent market value. According to analyst projections, AKYA’s forecast low is 2.4 with 2.4 as the target high. To hit the forecast high, the stock’s price needs a -83.21% plunge from its current level, while the stock would need to soar -83.21% for it to hit the projected low.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -23.03%. The 2025 estimates are for Akoya Biosciences Inc earnings to increase by 30.80%, but the outlook for the next 5-year period is at 22.40% per year.

AKYA Dividends

Akoya Biosciences Inc is expected to release its next quarterly earnings report in June.

BLACKROCK INC. holds the second largest percentage of outstanding shares, with 3.039% or 1.5 million shares worth $3.51 million as of 2024-06-30.

Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . With 882.32 shares estimated at $1.21 million under it, the former controlled 1.77% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 1.33% of the shares, roughly 661.97 shares worth around $0.91 million.